Ras-effector interactions: After one decade

Current Opinion in Structural Biology

Volumn 13, Issue 1, 2003, Pages 122-129

  Herrmann, Christian ^a  

^a MAX PLANCK INSTITUTE OF MOLECULAR PHYSIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; EPIDERMAL GROWTH FACTOR; GALECTIN 1; GUANOSINE DIPHOSPHATE; GUANOSINE TRIPHOSPHATASE; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; GUANOSINE TRIPHOSPHATE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN CDC42; PROTEIN KINASE N; PROTEIN P21; RAB PROTEIN; RAC PROTEIN; RAF PROTEIN; RAL PROTEIN; RAN PROTEIN; RAP PROTEIN; RAS PROTEIN; RHO FACTOR;

BINDING SITE; CELL STRAIN COS7; ENERGY METABOLISM; ENZYME ACTIVATION; KINETICS; MOLECULAR DYNAMICS; MOLECULAR MECHANICS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; SACCHAROMYCES CEREVISIAE; SCHIZOSACCHAROMYCES POMBE; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS; THERMODYNAMICS;

EID: 0037308836     PISSN: 0959440X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-440X(02)00007-6     Document Type: Review

References (64)

1. Bishop A.L., Hall A. Rho GTPases and their effector proteins. Biochem. J. 348:2000;241-255.
2. Sahai E., Olson M.F., Marshall C.J. Cross-talk between Ras and Rho signalling pathways in transformation favours proliferation and increased motility. EMBO J. 20:2001;755-766.
3. Sahai E., Marshall C.J. Rho GTPases and cancer. Nat. Rev. 2:2002;133-142.
4. Segev N. Ypt and Rab GTPases: insight into functions through novel interactions. Curr. Opin. Cell Biol. 13:2001;500-511.
5. Macara I.G. Transport into and out of the nucleus. Microbiol. Mol. Biol. Rev. 65:2001;570-594.
6. Niemann H.H., Knetsch M.L.W., Scherer A., Manstein D.J., Kull F.J. Crystal structure of a dynamin GTPase domain in both nucleotide-free and GDP-bound forms. EMBO J. 20:2001;5813-5821.
7. Prakash B., Praefcke G.J.K., Renault L., Wittinghofer A., Herrmann C. Structure of human guanylate-binding protein 1 representing a unique class of GTP-binding proteins. Nature. 403:2000;567-571.
8. Geyer M., Schweins T., Herrmann C., Prisner T., Wittinghofer A., Kalbitzer H.R. Conformational transitions in p21ras and in its complexes with the effector protein Raf-RBD and the GTPase activating protein GAP. Biochemistry. 35:1996;10308-10320.
9. Ito Y., Yamasaki K., Iwahara J., Terada T., Kamiya A., Shirouzu M., Muto Y., Kawai G., Yokoyama S., Laue E.D.et al. Regional polysterism in the GTP-bound form of the human c-Ha-Ras protein. Biochemistry. 36:1997;9109-9119.
10. Herrmann C., Horn G., Spaargaren M., Wittinghofer A. Differential interaction of the ras family GTP-binding proteins H-Ras, Rap1A, and R-Ras with the putative effector molecules Raf kinase and Ral-guanine nucleotide exchange factor. J. Biol. Chem. 271:1996;6794-6800.
11. Wang Y., Waldron R.T., Dhaka A., Patel A., Riley M.M., Rozengurt E., Colicelli J. The RAS effector RIN1 directly competes with RAF and is regulated by 14-3-3 proteins. Mol. Cell Biol. 22:2002;916-926.
12. Prior I.A., Harding A., Yan J., Sluimer J., Parton R.G., Hancock J.F. GTP-dependent segregation of H-ras from lipid rafts is required for biological activity. Nat. Cell Biol. 3:2001;368-375 H-Ras and K-Ras are found to be localized in different microdomains of the plasma membrane. The redistribution of H-Ras from lipid rafts to bulk membrane, controlled by GTP binding, is important for efficient activation of Raf.
13. Voice J.K., Klemke R.L., Le A., Jackson J.H. Four human Ras homologs differ in their abilities to activate Raf-1, induce transformation, and stimulate cell motility. J. Biol. Chem. 274:1999;17164-17170.
14. Nassar N., Horn G., Herrmann C., Scherer A., McCormick F., Wittinghofer A. The 2.2 Å crystal structure of the Ras-binding domain of the serine/threonine kinase c-Raf1 in complex with Rap1A and a GTP analogue. Nature. 375:1995;554-560.
15. Geyer M., Herrmann C., Wohlgemuth S., Wittinghofer A., Kalbitzer H.R. Structure of the Ras-binding domain of RalGEF and implications for Ras binding and signalling. Nat. Struct. Biol. 4:1997;694-699.
16. Huang L., Weng X.W., Hofer F., Martin G.S., Kim S.H. Three-dimensional structure of the Ras-interacting domain of RalGDS. Nat. Struct. Biol. 4:1997;609-615.
17. Kigawa T., Endo M., Ito Y., Shirouzu M., Kikuchi A., Yokoyama S. Solution structure of the Ras-binding domain of RGL. FEBS Lett. 441:1998;413-418.
18. Esser D., Bauer B., Wolthuis R.M.F., Wittinghofer A., Cool R.H., Bayer P. Structure determination of the Ras-binding domain of the Ral-specific guanine nucleotide exchange factor Rlf. Biochemistry. 37:1998;13453-13462.
19. Walker E.H., Perisic O., Ried C., Stephens L., Williams R.L. Structural insights into phosphoinositide 3-kinase catalysis and signalling. Nature. 402:1999;313-320.
20. Gronwald W., Huber F., Grunewald P., Sporner M., Wohlgemuth S., Herrmann C., Kalbitzer H.R. Solution structure of the Ras binding domain of the protein kinase Byr2 from Schizosaccharomyces pombe. Structure. 9:2001;1029-1041.
21. Huang L., Hofer F., Martin G.S., Kim S.H. Structural basis for the interaction of Ras with RalGDS. Nat. Struct. Biol. 5:1998;422-426.
22. Vetter I.R., Linnemann T., Wohlgemuth S., Geyer M., Kalbitzer H.R., Herrmann C., Wittinghofer A. Structural and biochemical analysis of Ras-effector signaling via RalGDS. FEBS Lett. 451:1999;175-180.
23. Pacold M.E., Suire S., Perisic O., Lara-Gonzalez S., Davis C.T., Walker E.H., Hawkins P.T., Stephens L., Eccleston J.F., Williams R.L. Crystal structure and functional analysis of Ras binding to its effector phosphoinositide 3-kinase gamma. Cell. 103:2000;931-943 The crystal structure of PI3Kγ in complex with Ras has been solved, revealing a significant conformational change and thereby suggesting an allosteric mechanism of activation. Specific differences compared to the complexes of Ras with Raf and RalGDS are highlighted; a loop in the RBD seems to be responsible for these. Particularly, direct contacts of Ras not only with the RBD but also with the catalytic domain of PI3Kγ are established. In addition, the paper shows interesting data on the kinetics of interaction and a mutational analysis of the interaction - including PI3Kγ activation in vivo.
24. Scheffzek K., Grunewald P., Wohlgemuth S., Kabsch W., Tu H., Wigler M., Wittinghofer A., Herrmann C. The Ras-Byr2RBD complex: structural basis for Ras effector recognition in yeast. Structure. 9:2001;1043-1050.
25. Ponting C.P., Benjamin D.R. A novel family of ras-binding domains. Trends Biochem. Sci. 21:1996;422-425.
26. Schultz J., Milpetz F., Bork P., Ponting C.P. Smart, a simple modular architecture research tool - identification of signaling domains. Proc. Natl. Acad. Sci. U.S.A. 95:1998;5857-5864.
27. Letunic I., Goodstadt L., Dickens N.J., Doerks T., Schultz J., Mott R., Ciccarelli F., Copley R.R., Ponting C.P., Bork P. Recent improvements to the SMART domain-based sequence annotation resource. Nucleic Acids Res. 30:2002;242-244.
28. Kalhammer G., Bahler M., Schmitz F., Jockel J., Block C. Ras-binding domains - predicting function versus folding. FEBS Lett. 414:1997;599-602.
29. Boettner B., Govek E.E., Cross J., Van Aelst L. The junctional multidomain protein AF-6 is a binding partner of the Rap1A GTPase and associates with the actin cytoskeletal regulator profilin. Proc. Natl. Acad. Sci. U.S.A. 97:2000;9064-9069.
30. Kido M., Shima F., Satoh T., Asato T., Kariya K., Kataoka T. Critical function of the ras-associating domain as a primary ras-binding site for regulation of Saccharomyces cerevisiae adenylyl cyclase. J. Biol. Chem. 277:2002;3117-3123 With the help of a computer algorithm, a small protein domain in yeast adenylate cyclase was identified and shown to be responsible for Ras binding. Biochemical evidence and secondary structure prediction suggest high similarity to the RBDs of mammalian effectors such as Raf, RalGDS and PI3K.
31. Maesaki R., Ihara K., Shimizu T., Kuroda S., Kaibuchi K., Hakoshima T. The structural basis of Rho effector recognition revealed by the crystal structure of human RhoA complexed with the effector domain of PKN/PRK1. Mol. Cell. 4:1999;793-803.
32. Abdul-Manan N., Aghazadeh B., Liu G.A., Majumdar A., Ouerfelli O., Siminovitch K.A., Rosen M.K. Structure of Cdc42 in complex with the GTPase-binding domain of the 'Wiskott-Aldrich syndrome' protein. Nature. 399:1999;379-383.
33. Mott H.R., Owen D., Nietlispach D., Lowe P.N., Manser E., Lim L., Laue E.D. Structure of the small G protein Cdc42 bound to the GTPase-binding domain of ACK. Nature. 399:1999;384-388.
34. Kim A.S., Kakalis L.T., Abdul-Manan M., Liu G.A., Rosen M.K. Autoinhibition and activation mechanisms of the Wiskott-Aldrich syndrome protein. Nature. 404:2000;151-158.
35. Hoffman G.R., Cerione R.A. Flipping the switch: the structural basis for signaling through the CRIB motif. Cell. 102:2000;403-406.
36. Lei M., Lu W.G., Meng W.Y., Parrini M.C., Eck M.J., Mayer B.J., Harrison S.C. Structure of PAK1 in an autoinhibited conformation reveals a multistage activation switch. Cell. 102:2000;387-397 The crystal structure of the complex between the regulatory and catalytic fragments of PAK1 shows how intramolecular inhibition of the kinase is achieved and suggests a mechanism of activation by binding Cdc42 or Rac. The inhibitory switch (IS) domain at one end blocks the catalytic site and at the other end forms a dimer contact with the IS domain of another PAK molecule. Supported by observations of WASP activation [32,34], a mechanism is suggested whereby Cdc42 or Rac binding leads to major structural rearrangements of the IS domain and thereby release of autoinhibition and dissociation of the dimer.
37. ••]).
38. Vetter I.R., Nowak C., Nishimoto T., Kuhlmann J., Wittinghofer A. Structure of a Ran-binding domain complexed with Ran bound to a GTP analogue: implications for nuclear transport. Nature. 398:1999;39-46.
39. Vetter I.R., Arndt A., Kutay U., Gorlich D., Wittinghofer A. Structural view of the Ran-Importin beta interaction at 2.3 Å resolution. Cell. 97:1999;635-646.
40. Vetter I.R., Wittinghofer A. Signal transduction - the guanine nucleotide-binding switch in three dimensions. Science. 294:2001;1299-1304.
41. Ostermeier C., Brunger A.T. Structural basis of Rab effector specificity: crystal structure of the small G protein Rab3A complexed with the effector domain of rabphilin-3A. Cell. 96:1999;363-374.
42. Pereira-Leal J.B., Seabra M.C. The mammalian Rab family of small GTPases: definition of family and subfamily sequence motifs suggests a mechanism for functional specificity in the Ras superfamily. J. Mol. Biol. 301:2000;1077-1087.
43. Corbett K.D., Alber T. The many faces of Ras: recognition of small GTP-binding proteins. Trends Biochem. Sci. 26:2001;710-716.
44. Linnemann T., Geyer M., Jaitner B.K., Block C., Kalbitzer H.R., Wittinghofer A., Herrmann C. Thermodynamic and kinetic characterization of the interaction between the Ras binding domain of AF6 and members of the Ras subfamily. J. Biol. Chem. 274:1999;13556-13562.
45. Kitayama H., Sugimoto Y., Matsuzaki T., Ikawa Y., Noda M. A ras-related gene with transformation suppressor activity. Cell. 56:1989;77-84.
46. Lo C.L., Chothia C., Janin J. The atomic structure of protein-protein recognition sites. J. Mol. Biol. 285:1999;2177-2198.
47. Rudolph M.G., Linnemann T., Grunewald P., Wittinghofer A., Vetter I.R., Herrmann C. Thermodynamics of Ras/effector and Cdc42/effector interactions probed by isothermal titration calorimetry. J. Biol. Chem. 276:2001;23914-23921 An extensive study of the thermodynamics of interactions between different Ras proteins and effectors shows dramatically different contributions from enthalpy and entropy changes, despite the high similarities in the structures of the complexes.
48. White M.A., Vale T., Camonis J.H., Schaefer E., Wigler M.H. A role for the Ral guanine nucleotide dissociation stimulator in mediating Ras-induced transformation. J. Biol. Chem. 271:1996;16439-16442.
49. Rodriguezviciana P., Warne P.H., Khwaja A., Marte B.M., Pappin D., Das P., Waterfield M.D., Ridley A., Downward J. Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras. Cell. 89:1997;457-467.
50. Webb C.P., Vanaelst L., Wigler M.H., Vandewoude G.F. Signaling pathways in Ras-mediated tumorigenicity and metastasis. Proc. Natl. Acad. Sci. U.S.A. 95:1998;8773-8778.
51. Bauer B., Mirey G., Vetter I.R., Valencia A., Wittinghofer A., Camonis J.H., Cool R.H. Effector recognition by the small GTP-binding proteins Ras and Ral. J. Biol. Chem. 274:1999;17763-17770.
52. Shirouzu M., Hashimoto K., Kikuchi A., Yokoyama S. Double-mutant analysis of the interaction of Ras with the Ras-binding domain of RGL. Biochemistry. 38:1999;5103-5110.
53. Sydor J.R., Engelhard M., Wittinghofer A., Goody R.S., Herrmann C. Transient kinetic studies on the interaction of Ras and the Ras-binding domain of c-Raf-1 reveal rapid equilibration of the complex. Biochemistry. 37:1998;14292-14299.
54. Linnemann T., Kiel C., Herter P., Herrmann C. The activation of RalGDS can be achieved independently of its Ras binding domain - implications of an activation mechanism in Ras effector specificity and signal distribution. J. Biol. Chem. 277:2002;7831-7837.
55. Spoerner M., Herrmann C., Vetter I.R., Kalbitzer H.R., Wittinghofer A. Dynamic properties of the Ras switch I region and its importance for binding to effectors. Proc. Natl. Acad. Sci. U.S.A. 98:2001;4944-4949 A combination of NMR, X-ray and biochemical studies demonstrates the importance of the relationship between conformational dynamics and the interaction between Ras and effectors. Thr35 in Ras is strictly conserved in all small GTPases - not even substitution by serine is tolerated - presumably because of its role in the control of switch dynamics.
56. Fridman M., Walker F., Catimel B., Domagala T., Nice E., Burgess A. c-Raf-1 RBD associates with a subset of active v-H-Ras. Biochemistry. 39:2000;15603-15611.
57. Inoue K., Yamada H., Akasaka K., Hermann C., Kremer W., Maurer T., Doker R., Kalbitzer H.R. Pressure-induced local unfolding of the Ras binding domain of RalGDS. Nat. Struct. Biol. 7:2000;547-550.
58. Inoue K., Maurer T., Yamada H., Herrmann C., Horn G., Kalbitzer H.R., Akasaka K. High-pressure NMR study of the complex of a GTPase Rap1A with its effector RalGDS - a conformational switch in RalGDS revealed from non-linear pressure shifts. FEBS Lett. 506:2001;180-184 Extending the investigations on different structural substates of the RBD of RalGDS using high-pressure NMR [57], this study shows nicely how conformational equilibria can be shifted and conformational changes be made more pronounced by interaction with a partner protein. These changes are suggested to be relevant to intramolecular transport of the signal.
59. Akasaka K., Li H. Low-lying excited states of proteins revealed from nonlinear pressure shifts in H-1 and N-15 NMR. Biochemistry. 40:2001;8665-8671 For eight different proteins, NMR chemical shifts are analyzed at high pressures (up to 2000 bar). According to nonlinear pressure dependence, the co-existence of different protein conformers is indicated, the populations of which can be shifted by changing the pressure. The authors point to the importance of 'non-native' states of the protein, which have a low population and therefore are not visible under normal conditions. These states could be essential to function and their structure could be investigated at high pressure.
60. Kitahara R., Yamada H., Akasaka K. Two folded conformers of ubiquitin revealed by high-pressure NMR. Biochemistry. 40:2001;13556-13563.
61. Koradi R., Billeter M., Wuthrich K. Molmol - a program for display and analysis of macromolecular structures. J. Mol. Graph. 14:1996;51-55.
62. Schomburg D., Reichelt J. BRAGI - a comprehensive protein modeling program system. J. Mol. Graph. 6:1988;161-165.
63. Elad-Sfadia G., Haklai R., Ballan E., Gabius H.J., Kloog Y. Galectin-1 augments Ras activation and diverts Ras signals to Raf-1 at the expense of phosphoinositide 3-kinase. J. Biol. Chem. 277:2002;37169-37175.
64. Suire S., Hawkins P., Stephens L. Activation of phosphoinositide 3-kinase gamma by Ras. Curr. Biol. 12:2002;1068-1075.